S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSE:MMS

Maximus (MMS) Stock Forecast, Price & News

$84.31
-0.12 (-0.14%)
(As of 06/9/2023 ET)
Compare
Today's Range
$83.73
$84.40
50-Day Range
$78.03
$84.46
52-Week Range
$54.46
$85.25
Volume
159,136 shs
Average Volume
366,708 shs
Market Capitalization
$5.12 billion
P/E Ratio
30.00
Dividend Yield
1.33%
Price Target
$100.00

Maximus MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
18.6% Upside
$100.00 Price Target
Short Interest
Healthy
2.34% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.11mentions of Maximus in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$156,515 Sold Last Quarter
Proj. Earnings Growth
14.03%
From $4.42 to $5.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.70 out of 5 stars

Business Services Sector

37th out of 330 stocks

Business Services, Not Elsewhere Classified Industry

17th out of 89 stocks


MMS stock logo

About Maximus (NYSE:MMS) Stock

MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S. state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions and includes appeals and assessment services, system and application development, IT modernization, and maintenance services. The Outside the U.S segment provides BPS for international governments and commercial clients. The company was founded by David V. Mastran in 1975 and is headquartered in McLean, VA.

Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

MMS Stock News Headlines

Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Maximus wins major UK government contract
Maximus (NYSE: MMS)
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Reviewing Quhuo (NASDAQ:QH) & Maximus (NYSE:MMS)
Maximus (NYSE:MMS) Upgraded to "Buy" by StockNews.com
Maximus (NYSE:MMS) Issues Earnings Results
Maximus, Inc. (MMS) To Go Ex-Dividend on May 12th
See More Headlines

MMS Price History

MMS Company Calendar

Last Earnings
5/03/2023
Ex-Dividend for 5/31 Dividend
5/12/2023
Dividend Payable
5/31/2023
Today
6/09/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Data Processing & Outsourced Services
CUSIP
57793310
Employees
39,500
Year Founded
1975

Price Target and Rating

Average Stock Price Forecast
$100.00
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$100.00
Forecasted Upside/Downside
+18.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$203.83 million
Pretax Margin
4.93%

Debt

Sales & Book Value

Annual Sales
$4.63 billion
Cash Flow
$6.62 per share
Book Value
$25.23 per share

Miscellaneous

Free Float
59,994,000
Market Cap
$5.12 billion
Optionable
Optionable
Beta
0.70

Social Links


Key Executives

  • Bruce L. CaswellBruce L. Caswell
    President, Chief Executive Officer & Director
  • David Mutryn
    Chief Financial Officer & Treasurer
  • Michael S. Weiner
    Chief Medical Officer
  • John W. Lambeth
    Chief Information Officer
  • Elisabeth Schmidt
    Senior VP-Technology & Consulting Services













MMS Stock - Frequently Asked Questions

Should I buy or sell Maximus stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MMS shares.
View MMS analyst ratings
or view top-rated stocks.

What is Maximus' stock price forecast for 2023?

1 brokerages have issued twelve-month target prices for Maximus' stock. Their MMS share price forecasts range from $100.00 to $100.00. On average, they expect the company's share price to reach $100.00 in the next year. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for MMS
or view top-rated stocks among Wall Street analysts.

How have MMS shares performed in 2023?

Maximus' stock was trading at $73.33 at the beginning of 2023. Since then, MMS shares have increased by 15.0% and is now trading at $84.31.
View the best growth stocks for 2023 here
.

When is Maximus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our MMS earnings forecast
.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) posted its earnings results on Wednesday, May, 3rd. The health services provider reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.78 by $0.02. The health services provider had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.20 billion. Maximus had a trailing twelve-month return on equity of 15.37% and a net margin of 3.62%. Maximus's quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the company earned $1.07 EPS.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Tuesday, April 11th. Stockholders of record on Monday, May 15th will be given a dividend of $0.28 per share on Wednesday, May 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Friday, May 12th.
Read our dividend analysis for MMS
.

Is Maximus a good dividend stock?

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.33%. The dividend payout ratio is 39.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 22.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

What guidance has Maximus issued on next quarter's earnings?

Maximus issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $4.00-$4.30 for the period, compared to the consensus estimate of $3.61. The company issued revenue guidance of $4.85 billion-$5.00 billion, compared to the consensus revenue estimate of $4.94 billion.

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.77%), Victory Capital Management Inc. (11.41%), FMR LLC (9.98%), Mackenzie Financial Corp (4.39%), State Street Corp (4.32%) and Geode Capital Management LLC (2.07%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends
.

How do I buy shares of Maximus?

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $84.31.

How much money does Maximus make?

Maximus (NYSE:MMS) has a market capitalization of $5.12 billion and generates $4.63 billion in revenue each year. The health services provider earns $203.83 million in net income (profit) each year or $2.81 on an earnings per share basis.

How many employees does Maximus have?

The company employs 39,500 workers across the globe.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.

This page (NYSE:MMS) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -